Intensity-modulated Radiation Therapy From 70Gy to 80Gy in Localized Prostate Cancer

The objective is to report outcomes,including grade ≥2 overall late rectal and urinary toxicity and biochemical control rates in patients treated with IMRT (70 gy, 74 Gy and 80 Gy)

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Prostate Cancer Genital Diseases Genital Diseases, Male Genital Neoplasms, Male Male Urogenital Diseases Neoplasms Neoplasms by Site Prostatic Diseases Prostatic Neoplasms Urogenital Diseases Urogenital Neoplasms

Age range

18 year and older

Sex eligibility

Male

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Consecutive patients from June 2000 to December 2010 with

untreated histologically confirmed adenocarcinoma of the prostate
stage T1c-T4 N0 M0 according to the 1992 American Joint Committee on Cancer staging system

Exclusion criteria

Patients with positive pelvic lymphadenectomy or radiological positives nodes

Treatment and study plan

Intensity-Modulated Radiation Therapy

Radiation

Primary outcomes

grade≥ 2 overall late rectal 5 years after the end of radiotherapy

Time frame: 60 months

Sponsors and collaborators

Lead sponsor

Institut de Cancérologie de Lorraine

Other

Registry information

Important dates

Study start: 2014
Primary completion: 2015
Study completion: 2015
First posted: Nov 28, 2016
Registry last updated: Nov 28, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed